SE0004229D0 - Inhalation of nitric oxide - Google Patents

Inhalation of nitric oxide

Info

Publication number
SE0004229D0
SE0004229D0 SE0004229A SE0004229A SE0004229D0 SE 0004229 D0 SE0004229 D0 SE 0004229D0 SE 0004229 A SE0004229 A SE 0004229A SE 0004229 A SE0004229 A SE 0004229A SE 0004229 D0 SE0004229 D0 SE 0004229D0
Authority
SE
Sweden
Prior art keywords
nitric oxide
treatment
combination
pulmonary vasoconstriction
airway constriction
Prior art date
Application number
SE0004229A
Other languages
English (en)
Swedish (sv)
Inventor
Goeran Hedenstierna
Luni Chen
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Priority to SE0004229A priority Critical patent/SE0004229D0/xx
Publication of SE0004229D0 publication Critical patent/SE0004229D0/xx
Priority to AU2002214519A priority patent/AU2002214519B2/en
Priority to AT01983064T priority patent/ATE354375T1/de
Priority to EEP200300226A priority patent/EE200300226A/xx
Priority to ARP010105331A priority patent/AR031348A1/es
Priority to CNB018208940A priority patent/CN100443119C/zh
Priority to CA002429224A priority patent/CA2429224A1/en
Priority to US10/416,883 priority patent/US20040028753A1/en
Priority to PCT/SE2001/002542 priority patent/WO2002040052A1/en
Priority to AU1451902A priority patent/AU1451902A/xx
Priority to EP01983064A priority patent/EP1339428B1/de
Priority to NZ526295A priority patent/NZ526295A/en
Priority to ES01983064T priority patent/ES2282310T3/es
Priority to CZ20031617A priority patent/CZ20031617A3/cs
Priority to JP2002542424A priority patent/JP2004513928A/ja
Priority to IL15596801A priority patent/IL155968A0/xx
Priority to DE60126814T priority patent/DE60126814T2/de
Priority to PL01362023A priority patent/PL362023A1/xx
Priority to SK731-2003A priority patent/SK7312003A3/sk
Priority to ZA200303845A priority patent/ZA200303845B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0004229A 2000-11-17 2000-11-17 Inhalation of nitric oxide SE0004229D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE0004229A SE0004229D0 (sv) 2000-11-17 2000-11-17 Inhalation of nitric oxide
SK731-2003A SK7312003A3 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
PCT/SE2001/002542 WO2002040052A1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
EP01983064A EP1339428B1 (de) 2000-11-17 2001-11-15 Inhalation von stickoxid
EEP200300226A EE200300226A (et) 2000-11-17 2001-11-15 Lämmastikoksiidi inhaleerimine
ARP010105331A AR031348A1 (es) 2000-11-17 2001-11-15 Inhalacion de oxido nitrico
CNB018208940A CN100443119C (zh) 2000-11-17 2001-11-15 一氧化氮的吸入
CA002429224A CA2429224A1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
US10/416,883 US20040028753A1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
AU2002214519A AU2002214519B2 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
AU1451902A AU1451902A (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
AT01983064T ATE354375T1 (de) 2000-11-17 2001-11-15 Inhalation von stickoxid
NZ526295A NZ526295A (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
ES01983064T ES2282310T3 (es) 2000-11-17 2001-11-15 Inhalacion de oxido nitrico.
CZ20031617A CZ20031617A3 (cs) 2000-11-17 2001-11-15 Inhalace oxidu dusnatého
JP2002542424A JP2004513928A (ja) 2000-11-17 2001-11-15 一酸化窒素の吸入
IL15596801A IL155968A0 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
DE60126814T DE60126814T2 (de) 2000-11-17 2001-11-15 Inhalation von stickoxid
PL01362023A PL362023A1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
ZA200303845A ZA200303845B (en) 2000-11-17 2003-05-19 Inhalation of nitric oxide.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004229A SE0004229D0 (sv) 2000-11-17 2000-11-17 Inhalation of nitric oxide

Publications (1)

Publication Number Publication Date
SE0004229D0 true SE0004229D0 (sv) 2000-11-17

Family

ID=20281873

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0004229A SE0004229D0 (sv) 2000-11-17 2000-11-17 Inhalation of nitric oxide

Country Status (19)

Country Link
US (1) US20040028753A1 (de)
EP (1) EP1339428B1 (de)
JP (1) JP2004513928A (de)
CN (1) CN100443119C (de)
AR (1) AR031348A1 (de)
AT (1) ATE354375T1 (de)
AU (2) AU1451902A (de)
CA (1) CA2429224A1 (de)
CZ (1) CZ20031617A3 (de)
DE (1) DE60126814T2 (de)
EE (1) EE200300226A (de)
ES (1) ES2282310T3 (de)
IL (1) IL155968A0 (de)
NZ (1) NZ526295A (de)
PL (1) PL362023A1 (de)
SE (1) SE0004229D0 (de)
SK (1) SK7312003A3 (de)
WO (1) WO2002040052A1 (de)
ZA (1) ZA200303845B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750238B1 (en) 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US6756047B2 (en) * 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
US7049326B2 (en) 2000-05-12 2006-05-23 The University Of Toledo Method and compositions for temporarily incapacitating subjects
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
EP1400243A1 (de) * 2002-09-19 2004-03-24 Tanabe Seiyaku Co., Ltd. Aktivator von Kalzium-abhängiger Kaliumkanälen
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
DK176782B1 (da) * 2006-08-04 2009-08-17 Innovision As Fremgangsmåde til at kompensere for effekten af recirkulation af blodoplöselig gas på bestemmelse af pulmonal blodgennemströmning i gentagne tests med genånding af inert gas
EP3650408A1 (de) 2011-10-03 2020-05-13 NitricGen, Inc. Vorrichtung und verfahren zur erzeugung von stickoxid in kontrollierten und genauen mengen
US20150272988A1 (en) * 2012-03-07 2015-10-01 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
EP2968827B1 (de) 2013-03-15 2019-02-20 The General Hospital Corporation Synthese von stickoxidgas zur inhalation
MX370385B (es) 2013-03-15 2019-12-11 Massachusetts Gen Hospital Sintesis inspiratoria de oxido nitrico.
ES2822215T3 (es) 2014-10-20 2021-04-29 Massachusetts Gen Hospital Sistemas y métodos de síntesis de óxido nítrico
BR112018069582A2 (pt) 2016-03-25 2019-01-22 Massachusetts Gen Hospital sistemas e métodos de entrega para síntese elétrica de plasma de óxido nítrico
WO2018157175A1 (en) 2017-02-27 2018-08-30 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
BR112019016708B1 (pt) 2017-02-27 2024-01-30 Third Pole, Inc Sistemas de geração de óxido nítrico
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
WO2018183811A1 (en) 2017-03-31 2018-10-04 The General Hospital Corporation Systems and methods for a cooled nitric oxide generator
WO2020232414A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Architectures for production of nitric oxide
EP3969416A4 (de) 2019-05-15 2023-11-01 Third Pole, Inc. Systeme und vorrichtungen zur erzeugung von stickoxid
CN114269685A (zh) 2019-05-15 2022-04-01 第三极股份有限公司 用于一氧化氮生成的电极
EP4069069A4 (de) 2020-01-11 2024-07-03 Third Pole, Inc. Systeme und verfahren zur stickoxid-erzeugung mit feuchtigkeitsregelung
EP4167920A4 (de) 2020-06-18 2024-06-12 Third Pole, Inc. Systeme und verfahren zur vorbeugung und behandlung von infektionen mit stickoxid
WO2022082072A1 (en) 2020-10-16 2022-04-21 Third Pole, Inc. Nitric oxide generation process controls
WO2022240964A1 (en) * 2021-05-11 2022-11-17 Pharmazz, Inc. Pharmaceutical composition and method for treatment of acute respiratory distress syndrome (ards) in corona virus disease (covid-19)
EP4405019A4 (de) 2021-09-23 2025-07-16 Third Pole Inc Systeme und verfahren zur abgabe von stickoxid
WO2023201363A2 (en) 2022-04-14 2023-10-19 Third Pole, Inc. Delivery of medicinal gas in a liquid medium

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537906A (en) * 1982-12-06 1985-08-27 Merck Frosst Canada, Inc. Substituted phenylalkenoic acids and esters
US4536515A (en) * 1982-12-06 1985-08-20 Merck Frosst Canada, Inc. Substituted phenylalkenoic acids and esters
EP1875917A3 (de) * 1990-12-05 2012-11-28 The General Hospital Corporation Gasmischung zur Behandlung von Lungengefässverengung
AP2002002582A0 (en) * 1999-12-23 2002-09-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use

Also Published As

Publication number Publication date
NZ526295A (en) 2004-10-29
CN1481256A (zh) 2004-03-10
CZ20031617A3 (cs) 2004-02-18
IL155968A0 (en) 2003-12-23
EP1339428A1 (de) 2003-09-03
JP2004513928A (ja) 2004-05-13
AU1451902A (en) 2002-05-27
CA2429224A1 (en) 2002-05-23
ES2282310T3 (es) 2007-10-16
EP1339428B1 (de) 2007-02-21
CN100443119C (zh) 2008-12-17
US20040028753A1 (en) 2004-02-12
ZA200303845B (en) 2004-09-09
AR031348A1 (es) 2003-09-17
PL362023A1 (en) 2004-10-18
AU2002214519B2 (en) 2004-08-12
DE60126814T2 (de) 2007-10-25
WO2002040052A1 (en) 2002-05-23
DE60126814D1 (de) 2007-04-05
EE200300226A (et) 2003-08-15
ATE354375T1 (de) 2007-03-15
SK7312003A3 (en) 2004-02-03

Similar Documents

Publication Publication Date Title
SE0004229D0 (sv) Inhalation of nitric oxide
WO2001093846A3 (en) Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans
CA2146954A1 (en) Breath activated nicotine inhalers
IL112459A (en) Use of mometasone furoate in the manufacture of a medicament for treating airway passage and lung diseases
MXPA05010402A (es) Oxido nitrico en el tratamiento de la inflamacion.
ATE347361T1 (de) Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
NO20030337L (no) Anvendelse av hydroksyetylrutosider i fremstilling av medikamenter til behandling av vanlig forkjolelse, virus- og/eller bakterieinfeksjon i luftveiene og/eller oyne, rhinitt og hoyfeber
TR200001891T2 (tr) ASPB28- İnsan ensülini ve kullanımı.
RU2004105865A (ru) Новый способ лечения
SE0000601D0 (sv) Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
ATE418994T1 (de) Argon enthaltendes arzneimittel zum inhalieren und dessen verwendung zur behandlung von neurotoxizität
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
NO20073909L (no) Forstover-formulering
SE9903985D0 (sv) Use of nitric oxide
WO2005110052A3 (en) The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
Djuric et al. Environmental risk factors for cardiovascular disease in anesthesiologists and surgeons in the operating room and intensive care unit
Selcow Ancillary Medical Therapy: Help or Hindrance
MD2491F1 (en) Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment
Lara The role of nitric oxide in patients with mood and anxiety symptoms and in their pharmacological treatment
Butler Non-surgical alternatives to continous positive airway pressure
ECSP034864A (es) Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias
UA40926A (uk) Спосіб застосування "імуналу" для корекції факторів і механізмів неспецифічного та специфічного імунного захисту організму хворих на бронхіальну астму